Imperial College London
Alternate

Professor Toby Prevost

Faculty of Medicine, School of Public Health

Visiting Professor
 
 
 
//

Contact

 

a.prevost

 
 
//

Location

 

57Stadium HouseWhite City Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Hykin:2021:10.3310/hta25380,
author = {Hykin, P and Prevost, AT and Sivaprasad, S and Vasconcelos, JC and Murphy, C and Kelly, J and Ramu, J and Alshreef, A and Flight, L and Pennington, R and Hounsome, B and Lever, E and Metry, A and Poku, E and Yang, Y and Harding, SP and Lotery, A and Chakravarthy, U and Brazier, J},
doi = {10.3310/hta25380},
journal = {HEALTH TECHNOLOGY ASSESSMENT},
pages = {1--+},
title = {Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT},
url = {http://dx.doi.org/10.3310/hta25380},
volume = {25},
year = {2021}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Hykin,P
AU  - Prevost,AT
AU  - Sivaprasad,S
AU  - Vasconcelos,JC
AU  - Murphy,C
AU  - Kelly,J
AU  - Ramu,J
AU  - Alshreef,A
AU  - Flight,L
AU  - Pennington,R
AU  - Hounsome,B
AU  - Lever,E
AU  - Metry,A
AU  - Poku,E
AU  - Yang,Y
AU  - Harding,SP
AU  - Lotery,A
AU  - Chakravarthy,U
AU  - Brazier,J
DO  - 10.3310/hta25380
EP  - 1
PY  - 2021///
SN  - 1366-5278
SP  - 1
TI  - Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT
T2  - HEALTH TECHNOLOGY ASSESSMENT
UR  - http://dx.doi.org/10.3310/hta25380
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000663930900001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL  - 25
ER  -
Download